Agilent Technologies Inventory 2012-2026 | A

Agilent Technologies inventory from 2012 to 2026. Inventory can be defined as the total value of inventories in all stages of completion.
  • Agilent Technologies inventory for the quarter ending April 30, 2026 was $1.025B, a 5.45% increase year-over-year.
  • Agilent Technologies inventory for 2025 was $1.025B, a 5.45% increase from 2024.
  • Agilent Technologies inventory for 2024 was $0.972B, a 5.72% decline from 2023.
  • Agilent Technologies inventory for 2023 was $1.031B, a 0.67% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Agilent Technologies Annual Inventory
(Millions of US $)
2025 $1,025
2024 $972
2023 $1,031
2022 $1,038
2021 $830
2020 $720
2019 $679
2018 $638
2017 $575
2016 $533
2015 $541
2014 $574
2013 $1,066
2012 $1,014
2011 $898
Agilent Technologies Quarterly Inventory
(Millions of US $)
2025-10-31 $1,025
2025-07-31 $1,014
2025-04-30 $991
2025-01-31 $997
2024-10-31 $972
2024-07-31 $978
2024-04-30 $1,000
2024-01-31 $1,033
2023-10-31 $1,031
2023-07-31 $1,072
2023-04-30 $1,103
2023-01-31 $1,111
2022-10-31 $1,038
2022-07-31 $1,010
2022-04-30 $937
2022-01-31 $879
2021-10-31 $830
2021-07-31 $818
2021-04-30 $791
2021-01-31 $755
2020-10-31 $720
2020-07-31 $746
2020-04-30 $750
2020-01-31 $706
2019-10-31 $679
2019-07-31 $660
2019-04-30 $657
2019-01-31 $653
2018-10-31 $638
2018-07-31 $623
2018-04-30 $594
2018-01-31 $608
2017-10-31 $575
2017-07-31 $566
2017-04-30 $548
2017-01-31 $551
2016-10-31 $533
2016-07-31 $543
2016-04-30 $555
2016-01-31 $554
2015-10-31 $541
2015-07-31 $545
2015-04-30 $556
2015-01-31 $560
2014-10-31 $574
2014-07-31 $1,099
2014-04-30 $1,100
2014-01-31 $1,088
2013-10-31 $1,066
2013-07-31 $1,054
2013-04-30 $1,042
2013-01-31 $1,040
2012-10-31 $1,014
2012-07-31 $1,036
2012-04-30 $947
2012-01-31 $937
2011-10-31 $898
2011-07-31 $897
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.516B $6.948B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $174.688B 19.48
Stryker (SYK) United States $129.889B 24.88
Medtronic (MDT) Ireland $111.968B 15.57
EssilorLuxottica (ESLOY) France $107.724B 0.00
Boston Scientific (BSX) United States $91.831B 20.26
Medline (MDLN) United States $59.904B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.712B 0.00
GE HealthCare Technologies (GEHC) United States $33.391B 15.98
ResMed (RMD) United States $33.341B 22.26
Koninklijke Philips (PHG) Netherlands $27.260B 16.18
Terumo (TRUMY) Japan $19.854B 23.21
Zimmer Biomet Holdings (ZBH) United States $18.025B 11.36
Smith & Nephew SNATS (SNN) United Kingdom $14.227B 0.00
Insulet (PODD) United States $13.640B 39.54
Baxter (BAX) United States $8.854B 7.56
Sunny Optical Technology (SNPTF) China $8.381B 0.00
Bio-Rad Laboratories (BIO) United States $7.537B 28.15
Demant (WILYY) Denmark $6.395B 0.00
Lantheus Holdings (LNTH) United States $5.247B 15.90
Envista Holdings (NVST) United States $4.301B 21.99
BillionToOne (BLLN) United States $3.729B 0.00
DiaSorin S.p.A (DSRLF) Italy $3.666B 0.00
ICU Medical (ICUI) United States $3.141B 20.47
Prestige Consumer Healthcare (PBH) United States $2.676B 12.62
Haemonetics (HAE) United States $2.664B 11.65
LeMaitre Vascular (LMAT) United States $2.611B 48.16
Phibro Animal Health (PAHC) United States $2.347B 20.67
GN Store Nord (GNNDY) Denmark $2.270B 21.90
Neogen (NEOG) United States $2.050B 44.86
Shandong Weigao Medical Polymer (SHWGF) China $2.028B 0.00
Capricor Therapeutics (CAPR) United States $1.794B 0.00
AdaptHealth (AHCO) United States $1.654B 32.89
Curaleaf Holdings (CURLF) Canada $1.584B 0.00
Perrigo (PRGO) Ireland $1.495B 3.96
AtriCure (ATRC) United States $1.429B 0.00
Green Thumb Industries (GTBIF) United States $1.386B 15.91
Kestra Medical Technologies (KMTS) United States $1.043B 0.00
BioLife Solutions (BLFS) United States $0.953B 164.50
QuidelOrtho (QDEL) United States $0.943B 6.53
Lumexa Imaging Holdings (LMRI) United States $0.896B 0.00
InMode (INMD) Israel $0.857B 9.40
Omeros (OMER) United States $0.827B 6.49
Maravai LifeSciences Holdings (MRVI) United States $0.789B 0.00
Tilray Brands (TLRY) Canada $0.766B 0.00
CeriBell (CBLL) United States $0.683B 0.00
Brainsway (BWAY) Israel $0.546B 55.68
Valneva SE (VALN) France $0.532B 0.00
VAREX IMAGING (VREX) United States $0.468B 11.18
Cresco Labs (CRLBF) United States $0.458B 0.00
Canopy Growth (CGC) Canada $0.424B 0.00
Verano Holdings (VRNO) United States $0.415B 0.00
Viemed Healthcare (VMD) United States $0.367B 25.70
SNDL (SNDL) Canada $0.366B 0.00
Cerus (CERS) United States $0.363B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.311B 126.00
Evolus (EOLS) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.259B 0.00
MacroGenics (MGNX) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Accendra Health (ACH) United States $0.215B 2.96
Utah Medical Products (UTMD) United States $0.210B 18.94
High Tide (HITI) Canada $0.205B 0.00
OraSure Technologies (OSUR) United States $0.205B 0.00
Aurora Cannabis (ACB) Canada $0.194B 57.17
TerrAscend (TSNDF) Canada $0.193B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
Apyx Medical (APYX) United States $0.166B 0.00
Quanterix (QTRX) United States $0.158B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Sanara MedTech (SMTI) United States $0.152B 0.00
Sanuwave Health (SNWV) United States $0.145B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.143B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
Fonar (FONR) United States $0.115B 16.53
Jushi Holdings (JUSHF) United States $0.101B 0.00
FitLife Brands (FTLF) United States $0.090B 11.73
Exagen (XGN) United States $0.073B 0.00
Sharps Technology (STSS) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.064B 0.00
Biote (BTMD) United States $0.063B 3.46
INLIF (INLF) China $0.053B 0.00
Cytosorbents (CTSO) United States $0.038B 0.00
Veru (VERU) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.032B 26.91
United-Guardian (UG) United States $0.030B 14.23
Bonk (BNKK) United States $0.021B 0.00
Jin Medical (ZJYL) China $0.018B 0.00
Modular Medical (MODD) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
IM Cannabis (IMCC) Canada $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00